Provided by Tiger Trade Technology Pte. Ltd.

Adial Pharmaceuticals

5.82
+0.42007.78%
Pre-market: 5.36-0.4600-7.90%05:03 EDT
Volume:32.14K
Turnover:182.40K
Market Cap:15.28M
PE:-0.33
High:5.90
Open:5.35
Low:5.19
Close:5.40
52wk High:10.75
52wk Low:1.31
Shares:2.63M
Float Shares:1.82M
Volume Ratio:0.34
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.7100
EPS(LYR):-11.9306
ROE:-2011.64%
ROA:-40.02%
PB:-0.40
PE(LYR):-0.49

Loading ...

Adial Pharmaceuticals - Anticipates Board Changes and Legacy Member Resignations After Stockholder Approval - SEC Filing

THOMSON REUTERS
·
Aug 14

Adial Pharmaceuticals - Anticipates Termination of CFO Vinay Shah After 2026 Annual Meeting - SEC Filing

THOMSON REUTERS
·
Aug 14

Adial Pharmaceuticals CEO Cary Claiborne Set to Depart After Sept. 17 Annual Meeting; CDO Matthew Davidson Slated to Succeed

Reuters
·
Aug 14

Adial Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Aug 11

Adial Pharmaceuticals Inc Expected to Post a Loss of $1.03 a Share - Earnings Preview

Reuters
·
Aug 08

Adial Pharmaceuticals Initiated at Buy by Alliance Global Partners

Dow Jones
·
Aug 04

Adial Pharmaceuticals Inc : Alliance Global Partners Initiates Coverage with Buy Rating; Price Target $11

THOMSON REUTERS
·
Aug 03

Coastlands Capital LP Reports $8,689 Adial Pharmaceuticals Common Share Purchase

Reuters
·
Jul 17

Coastlands Capital LP Reports Adial Pharmaceuticals Common Share Purchase Worth $32,613.87

Reuters
·
Jul 13

Major Investor Quietly Boosts Stake in Adial Pharmaceuticals

TIPRANKS
·
Jul 02

Coastlands Capital LP Buys 25,000 Adial Pharma Shares Worth $65,000

Reuters
·
Jul 01

Adial Pharmaceuticals Initial Beneficial Ownership Filing Lists Coastlands Capital LP as 10% Owner

Reuters
·
Jun 30

Coastlands Capital Lp Reports 9.98% Passive Stake in Adial Pharmaceuticals as of June 17 - SEC Filing

THOMSON REUTERS
·
Jun 24

Adial Pharmaceuticals Closes First $32 Million Tranche of Financing

MT Newswires Live
·
Jun 16

Adial Pharmaceuticals grants inducement equity awards to new chief development officer, strategy EVP

Reuters
·
Jun 16

Adial Pharmaceuticals Expands Executive Leadership Team and Closes Pipe Financing

THOMSON REUTERS
·
Jun 16

Press Release: Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

Dow Jones
·
Jun 16

Adial Pharmaceuticals director Wendy B. Young files initial beneficial ownership statement

Reuters
·
Jun 16

Adial Pharmaceuticals Initiated at Buy by LUCID CAPITAL MARKETS

Dow Jones
·
Jun 16

Adial Pharmaceuticals initiated with a Buy at Lucid Capital

TIPRANKS
·
Jun 15